chr2-208325795-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015040.4(PIKFYVE):​c.2984A>T​(p.Gln995Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.972 in 1,613,742 control chromosomes in the GnomAD database, including 763,631 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.93 ( 66252 hom., cov: 31)
Exomes 𝑓: 0.98 ( 697379 hom. )

Consequence

PIKFYVE
NM_015040.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.44

Publications

30 publications found
Variant links:
Genes affected
PIKFYVE (HGNC:23785): (phosphoinositide kinase, FYVE-type zinc finger containing) Phosphorylated derivatives of phosphatidylinositol (PtdIns) regulate cytoskeletal functions, membrane trafficking, and receptor signaling by recruiting protein complexes to cell- and endosomal-membranes. Humans have multiple PtdIns proteins that differ by the degree and position of phosphorylation of the inositol ring. This gene encodes an enzyme (PIKfyve; also known as phosphatidylinositol-3-phosphate 5-kinase type III or PIPKIII) that phosphorylates the D-5 position in PtdIns and phosphatidylinositol-3-phosphate (PtdIns3P) to make PtdIns5P and PtdIns(3,5)biphosphate. The D-5 position also can be phosphorylated by type I PtdIns4P-5-kinases (PIP5Ks) that are encoded by distinct genes and preferentially phosphorylate D-4 phosphorylated PtdIns. In contrast, PIKfyve preferentially phosphorylates D-3 phosphorylated PtdIns. In addition to being a lipid kinase, PIKfyve also has protein kinase activity. PIKfyve regulates endomembrane homeostasis and plays a role in the biogenesis of endosome carrier vesicles from early endosomes. The protein plays a key role in cell entry of ebola virus and SARS-CoV-2 by endocytosis Mutations in this gene cause corneal fleck dystrophy (CFD); an autosomal dominant disorder characterized by numerous small white flecks present in all layers of the corneal stroma. Histologically, these flecks appear to be keratocytes distended with lipid and mucopolysaccharide filled intracytoplasmic vacuoles. [provided by RefSeq, Jul 2021]
PIKFYVE Gene-Disease associations (from GenCC):
  • fleck corneal dystrophy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.1307615E-6).
BP6
Variant 2-208325795-A-T is Benign according to our data. Variant chr2-208325795-A-T is described in ClinVar as Benign. ClinVar VariationId is 333909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015040.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIKFYVE
NM_015040.4
MANE Select
c.2984A>Tp.Gln995Leu
missense
Exon 20 of 42NP_055855.2Q9Y2I7-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIKFYVE
ENST00000264380.9
TSL:1 MANE Select
c.2984A>Tp.Gln995Leu
missense
Exon 20 of 42ENSP00000264380.4Q9Y2I7-1
PIKFYVE
ENST00000443896.5
TSL:1
n.*2335A>T
non_coding_transcript_exon
Exon 19 of 19ENSP00000407692.1F8WEZ0
PIKFYVE
ENST00000443896.5
TSL:1
n.*2335A>T
3_prime_UTR
Exon 19 of 19ENSP00000407692.1F8WEZ0

Frequencies

GnomAD3 genomes
AF:
0.930
AC:
141237
AN:
151878
Hom.:
66200
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.801
Gnomad AMI
AF:
0.996
Gnomad AMR
AF:
0.970
Gnomad ASJ
AF:
0.996
Gnomad EAS
AF:
0.943
Gnomad SAS
AF:
0.932
Gnomad FIN
AF:
0.997
Gnomad MID
AF:
0.975
Gnomad NFE
AF:
0.983
Gnomad OTH
AF:
0.939
GnomAD2 exomes
AF:
0.964
AC:
241668
AN:
250574
AF XY:
0.966
show subpopulations
Gnomad AFR exome
AF:
0.799
Gnomad AMR exome
AF:
0.985
Gnomad ASJ exome
AF:
0.997
Gnomad EAS exome
AF:
0.940
Gnomad FIN exome
AF:
0.997
Gnomad NFE exome
AF:
0.983
Gnomad OTH exome
AF:
0.978
GnomAD4 exome
AF:
0.976
AC:
1427050
AN:
1461746
Hom.:
697379
Cov.:
78
AF XY:
0.976
AC XY:
709734
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.796
AC:
26621
AN:
33464
American (AMR)
AF:
0.982
AC:
43927
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.996
AC:
26026
AN:
26122
East Asian (EAS)
AF:
0.957
AC:
37976
AN:
39696
South Asian (SAS)
AF:
0.941
AC:
81162
AN:
86246
European-Finnish (FIN)
AF:
0.996
AC:
53190
AN:
53418
Middle Eastern (MID)
AF:
0.964
AC:
5559
AN:
5766
European-Non Finnish (NFE)
AF:
0.984
AC:
1094072
AN:
1111934
Other (OTH)
AF:
0.969
AC:
58517
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
2012
4025
6037
8050
10062
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21650
43300
64950
86600
108250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.930
AC:
141347
AN:
151996
Hom.:
66252
Cov.:
31
AF XY:
0.932
AC XY:
69244
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.801
AC:
33131
AN:
41346
American (AMR)
AF:
0.970
AC:
14832
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.996
AC:
3449
AN:
3464
East Asian (EAS)
AF:
0.943
AC:
4859
AN:
5150
South Asian (SAS)
AF:
0.933
AC:
4492
AN:
4816
European-Finnish (FIN)
AF:
0.997
AC:
10580
AN:
10610
Middle Eastern (MID)
AF:
0.973
AC:
286
AN:
294
European-Non Finnish (NFE)
AF:
0.983
AC:
66827
AN:
68000
Other (OTH)
AF:
0.940
AC:
1983
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
453
905
1358
1810
2263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.977
Hom.:
54249
Bravo
AF:
0.922
TwinsUK
AF:
0.986
AC:
3657
ALSPAC
AF:
0.984
AC:
3794
ESP6500AA
AF:
0.807
AC:
3554
ESP6500EA
AF:
0.982
AC:
8442
ExAC
AF:
0.960
AC:
116496
Asia WGS
AF:
0.930
AC:
3235
AN:
3478
EpiCase
AF:
0.983
EpiControl
AF:
0.984

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Fleck corneal dystrophy (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.27
T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.61
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.42
T
MetaRNN
Benign
0.0000011
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.20
N
PhyloP100
1.4
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.040
Sift
Benign
0.096
T
Sift4G
Benign
0.24
T
Polyphen
0.0
B
Vest4
0.10
MPC
0.28
ClinPred
0.0086
T
GERP RS
4.2
Varity_R
0.085
gMVP
0.22
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs893254; hg19: chr2-209190519; COSMIC: COSV104578620; API